-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, E/RKPEQPosHBCLu9kVGTvu8vQlG49fvbW39tF2S0KCeTcvvVdpg4hQhD4lBhI5hT zHrU4aQVHjmf7zdNUDSJCw== 0000892569-07-000700.txt : 20070522 0000892569-07-000700.hdr.sgml : 20070522 20070522093054 ACCESSION NUMBER: 0000892569-07-000700 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070516 ITEM INFORMATION: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20070522 DATE AS OF CHANGE: 20070522 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOLASE TECHNOLOGY INC CENTRAL INDEX KEY: 0000811240 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] IRS NUMBER: 870442441 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19627 FILM NUMBER: 07869851 BUSINESS ADDRESS: STREET 1: 4 CROMWELL CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-361-1200 MAIL ADDRESS: STREET 1: 4 CROMWELL CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: LASER MEDICAL TECHNOLOGY INC DATE OF NAME CHANGE: 19941117 FORMER COMPANY: FORMER CONFORMED NAME: LASER ENDO TECHNIC CORP DATE OF NAME CHANGE: 19920708 FORMER COMPANY: FORMER CONFORMED NAME: PAMPLONA CAPITAL CORP DATE OF NAME CHANGE: 19911104 8-K 1 a30561e8vk.htm FORM 8-K Biolase Technology, Inc.
 

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
May 16, 2007
Date of Report (Date of earliest event reported)
BIOLASE TECHNOLOGY, INC.
(Exact name of registrant as specified in its charter)
         
Delaware   000-19627   87-0442441
(State of Incorporation)   (Commission File Number)   (IRS Employer
        Identification Number)
     
4 Cromwell, Irvine, California   92618
(Address of principal executive offices)   (Zip code)
(949) 361-1200
(Registrant’s telephone number including area code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

 

Item 5.02.    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(e) Approval of an amendment to the Biolase Technology, Inc. 2002 Stock Incentive Plan
     On May 16, 2007, at the 2007 annual meeting of stockholders, the stockholders of Biolase Technology, Inc. (the “Company”) approved an amendment (the “Amendment”) to the Company’s 2002 Stock Incentive Plan, as previously amended (the “Stock Incentive Plan”), that increased the number of shares of common stock available for issuance under the Stock Incentive Plan by an additional 1,000,000 shares to a total of 5,950,000 shares and that established an aggregate share limitation of 200,000 on the number of shares that may be used for granting full value awards. The Amendment became effective immediately upon receipt of the stockholder approval.
     The foregoing summary is qualified by reference to the Stock Incentive Plan, as amended, which is incorporated by reference to Appendix A of the Company’s Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 10, 2007.
Item 9.01.    Financial Statements and Exhibits.
(d) Exhibits
10.1    The Biolase Technology, Inc. 2002 Stock Incentive Plan (incorporated by reference to Appendix A of the Definitive Proxy Statement on Schedule 14A filed on April 10, 2007).

2

 

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  BIOLASE TECHNOLOGY, INC.
 		  
Date: May 21, 2007 By:   /s/ Richard Harrison  
      Richard Harrison  
      Executive Vice President,
Chief Financial Officer & Secretary 		  
 

3

 

EXHIBIT INDEX
     
Exhibit    
Number   Description
10.1
  The Biolase Technology, Inc. 2002 Stock Incentive Plan (incorporated by reference to Appendix A of the Definitive Proxy Statement on Schedule 14A filed on April 10, 2007).

-----END PRIVACY-ENHANCED MESSAGE-----